TY - JOUR AU - Zheng, H. AU - Chen, Y. AU - Chen, S. AU - Niu, Y. AU - Yang, L. AU - Li, B. PY - 2011 DA - 2011// TI - Expression and distribution of PPP2R5C gene in leukemia JO - J Hematol Oncol VL - 4 UR - https://doi.org/10.1186/1756-8722-4-21 DO - 10.1186/1756-8722-4-21 ID - Zheng2011 ER - TY - JOUR AU - Shen, Q. AU - Liu, S. AU - Chen, Y. AU - Yang, L. AU - Chen, S. AU - Wu, X. PY - 2013 DA - 2013// TI - Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation JO - J Hematol Oncol VL - 6 UR - https://doi.org/10.1186/1756-8722-6-64 DO - 10.1186/1756-8722-6-64 ID - Shen2013 ER - TY - JOUR AU - Chen, Y. AU - Liu, S. AU - Shen, Q. AU - Zha, X. AU - Zheng, H. AU - Yang, L. PY - 2013 DA - 2013// TI - Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells JO - DNA Cell Biol VL - 32 UR - https://doi.org/10.1089/dna.2013.2138 DO - 10.1089/dna.2013.2138 ID - Chen2013 ER - TY - JOUR AU - Zha, X. AU - Chen, S. AU - Yang, L. AU - Shi, L. AU - Li, B. AU - Wu, X. PY - 2012 DA - 2012// TI - Upregulated TCRzeta enhances interleukin-2 production in T-cells from patients with CML JO - DNA Cell Biol VL - 31 UR - https://doi.org/10.1089/dna.2012.1798 DO - 10.1089/dna.2012.1798 ID - Zha2012 ER - TY - JOUR AU - Sweet, K. AU - Zhang, L. AU - Pinilla-Ibarz, J. PY - 2013 DA - 2013// TI - Biomarkers for determining the prognosis in chronic myelogenous leukemia JO - J Hematol Oncol VL - 6 UR - https://doi.org/10.1186/1756-8722-6-54 DO - 10.1186/1756-8722-6-54 ID - Sweet2013 ER - TY - JOUR AU - Okabe, S. AU - Tauchi, T. AU - Katagiri, S. AU - Tanaka, Y. AU - Ohyashiki, K. PY - 2014 DA - 2014// TI - Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cells JO - J Hematol Oncol VL - 7 UR - https://doi.org/10.1186/1756-8722-7-37 DO - 10.1186/1756-8722-7-37 ID - Okabe2014 ER - TY - JOUR AU - Cilloni, D. AU - Saglio, G. PY - 2012 DA - 2012// TI - Molecular pathways: BCR-ABL JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-10-1613 DO - 10.1158/1078-0432.CCR-10-1613 ID - Cilloni2012 ER - TY - JOUR AU - Luca, A. AU - Maiello, M. R. AU - D’Alessio, A. AU - Pergameno, M. AU - Normanno, N. PY - 2012 DA - 2012// TI - The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches JO - Expert Opin Ther Targets VL - 16 UR - https://doi.org/10.1517/14728222.2011.639361 DO - 10.1517/14728222.2011.639361 ID - Luca2012 ER - TY - JOUR AU - Panigrahi, S. AU - Stetefeld, J. AU - Jangamreddy, J. R. AU - Mandal, S. AU - Mandal, S. K. AU - Los, M. PY - 2012 DA - 2012// TI - Modeling of molecular interaction between apoptin, BCR-Abl and CrkL–an alternative approach to conventional rational drug design JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0028395 DO - 10.1371/journal.pone.0028395 ID - Panigrahi2012 ER - TY - JOUR AU - Ozes, O. N. AU - Mayo, L. D. AU - Gustin, J. A. AU - Pfeffer, S. R. AU - Pfeffer, L. M. AU - Donner, D. B. PY - 1999 DA - 1999// TI - NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase JO - Nature VL - 401 UR - https://doi.org/10.1038/43466 DO - 10.1038/43466 ID - Ozes1999 ER - TY - JOUR AU - Mayo, L. D. AU - Donner, D. B. PY - 2001 DA - 2001// TI - A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.181181198 DO - 10.1073/pnas.181181198 ID - Mayo2001 ER - TY - JOUR AU - Sansone, P. AU - Bromberg, J. PY - 2012 DA - 2012// TI - Targeting the interleukin-6/Jak/stat pathway in human malignancies JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2010.31.8907 DO - 10.1200/JCO.2010.31.8907 ID - Sansone2012 ER - TY - JOUR AU - Shouse, G. P. AU - Cai, X. AU - Liu, X. PY - 2008 DA - 2008// TI - Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A JO - Mol Cell Biol VL - 28 UR - https://doi.org/10.1128/MCB.00983-07 DO - 10.1128/MCB.00983-07 ID - Shouse2008 ER - TY - JOUR AU - Saha, M. N. AU - Qiu, L. AU - Chang, H. PY - 2013 DA - 2013// TI - Targeting p53 by small molecules in hematological malignancies JO - J Hematol Oncol VL - 6 UR - https://doi.org/10.1186/1756-8722-6-23 DO - 10.1186/1756-8722-6-23 ID - Saha2013 ER -